Cited by 278Psoriasis: Treatment and PathogenesisT-cell and B-cell ImmunologyIL-33, ST2, and ILC Pathways

Human T H 17 Cells Are Long-Lived Effector Memory Cells

Open access
Kryczek, Ilona, Zhao, Ende, Liu, Yan, Wang, Yin, Vatan, Linhua, Szeliga, Wojciech, Moyer, Jeffrey, Klimczak, Aleksandra +2 more·2011·Science Translational Medicine

Abstract

Human T H 17 cells function as long-lived effector memory cells in the context of chronic disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.3002949

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Human Th17 cells give rise to distinct Th lineages, as measured by IFNγ and Foxp3+ cell expression, and have heightened self-renewal and survival capabilities.

    “Human Th17 cells were shown to give rise to distinct Th lineages, as measured through the expression of IFNγ, and Foxp3+ cells, heightened self-renewal, and survival capabilities [71,72].”
  • Th17 cells retain a stem cell-like phenotype through coordinated effects of HIF1α/Notch/Bcl-2 and are potent anti-tumor effectors.

    “Interestingly, Th17 cells retain a stem cell-like phenotype through the coordinated effects of HIF1α/Notch/Bcl-2 and are also potent anti-tumor effectors [71], suggesting that stemness might correlate with better immune responses.”
  • Despite phenotypic markers of terminal differentiation, Th17 cells have stem cell features and powerful functionalities.

    “For example, despite their phenotypic markers of terminal differentiation, Th17 cells have stem cell feature with powerful functionalities [71–73].”
  • Human TH17 cells have high self-renewal potential, potent persistence, apoptotic resistance in vivo, and plasticity to convert into other cell types.

    “Human TH17 cells were shown to have a high potential for self-renewal, potent persistence, apoptotic resistance in vivo and plasticity to convert into other cell types.”

    From T-cell aging in rheumatoid arthritis (2014) · cites this paper as [37]

  • Human TH17 cells are terminally differentiated memory T cells distinct from central memory and exhausted T cells.

    “IL-17 producing TH17 cells, which have recently been characterized as terminally differentiated memory T cells, distinct from both central memory T cells and exhausted T cells.”

    From T-cell aging in rheumatoid arthritis (2014) · cites this paper as [37]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 35 · Cited by 278

Authors
Kryczek, I., Zhao, E., Liu, Y., Wang, Y., Vatan, L., Szeliga, W., Moyer, J., Klimczak, A., Lange, A., & Zou, W.
Affiliations
  • University of Michigan (US)
  • Ludwik Hirszfeld Institute of Immunology and Experimental Therapy (PL)
Corresponding author
Zou, Weiping
Venue
Science Translational Medicine
Published
2011-10-12
Volume
3
Issue
104
Pages
104ra100-104ra100
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2103119361
Cited by
278
References
35
Citations by year
2026: 12 · 2025: 9 · 2024: 13 · 2023: 15 · 2022: 26 · 2021: 12 · 2020: 15 · 2019: 18 · 2018: 15 · 2017: 21 · 2016: 22 · 2015: 30 · 2014: 19 · 2013: 27 · 2012: 21
FWCI
9.93
Type
journal article
Language
en
Open access
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (P30-CA 46592, R01CA152470, R01CA156685, P50CA97248, P50CA097248, R01CA099985, P30CA046592)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Keywords
Th17 cells, effector memory T cells, T cell survival, apoptosis resistance, self-renewal, T cell plasticity, Bcl-2 family genes, hypoxia-inducible factor-1α, Notch signaling, graft-versus-host disease, ulcerative colitis, antitumor immunity, adoptive T cell therapy, autoimmune disease, cancer immunotherapy
MeSH terms
Animals, Autoimmune Diseases, Cell Differentiation, Gene Expression Regulation, Humans, Immunologic Memory, Phenotype, Cellular Senescence, Apoptosis, Gene Expression Profiling, Cell Line, Tumor, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Receptors, Notch, Th17 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review